The Office of Interprofessional Continuing Education (IPCE) supports the diverse learning needs of Advocate Health team members and providers. We accredit around 500 activities each year featuring a broad range of topics and formats. The CE Learning Platform houses all accredited education and stores learners’ transcripts and completion records. Contact us at cme@aah.org if you have questions.

Our Mission Statement

To foster collaborative healthcare practice through evidence‐based education designed to enhance our individual interprofessional team members’ and our healthcare teams’ competence and performance, to ultimately contribute to the optimization of patient outcomes and the promotion of high value care so we can help people live well.

Joint Accreditation Statement

In support of improving patient care, Advocate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CE Team Members

CME Analysts (WI): Jenni Binon, Jake Verkuilen
CME Analysts (IL): Karen Levins, Holly Spencer
CME Coordinators: Wala Majid (CMC), Keri Reed (IMMC)
AAHMG Education: Nicole Heilman (Manager), Yolanda Manson
Education Coordinator: Christina Bugajski
LMS Coordinator: Julie Eagan
Administrative Support: Sheree Meier
AVP Interprofessional Continuing Education: Kristin Ouweneel
CPE Administrator: Heather Raeder, PharmD, BCPS
CNE Administrator: Carissa Blumenshine, MSN, RN, NPD-BC, PCCN-K

IPCE Steering Committee

Leader:  Kristin Ouweneel​
Nursing: Carissa Blumenshine, MSN, RN, NPD-BC, PCCN-K; Stephanie Zidek, MSN, AGCNS-BC, RN-BC​
Pharmacy: Chad Smith, PharmD, MBA, BCPS, BCSCP; Christina Andros, PharmD, MBA, BCPS ; Heather Raeder, PharmD, BCPS
Medicine: Thomas Hansen, MD ​
Academic Affairs: Deb Simpson, PhD​

Disclosures

All CE team members and IPCE Steering Committee members have indicated that there are no relevant financial relationships with any ineligible companies to disclose.